Joanne Cox, MD, director of Children’s Hospital Boston’s Primary Care Center, answers questions about H1N1 during this Karson & Kennedy Morning Show on MIX 104.1. She dispels common myths and answers questions about the swine flu virus and vaccine, like:
How do you know if you have regular flu or H1N1?
Can you be immune if you’ve already had swine flu?
The Wall Street Journal features a story about a Children’s Hospital Boston patient with congenital heart disease who was stricken with H1N1 and required a new heart valve. Because the boy was too sick to undergo open-heart surgery, James Lock, MD, led a team that implanted the new valve using a catheter. Lock and Peter Laussen, MD, chief of cardiovascular critical care at Children’s, talk about how H1N1 presents a serious problem for children with heart disease.
Last week, a multicenter study led by Children’s reported good preliminary results in 30 patients receiving this catheter-implanted valve, which is threaded up a leg vein to the heart.
by Childrens Hospital Boston staff on October 29, 2009
In a special report from the Children’s Hospital Boston’s Emergency Department and Intensive Care Unit, CNN’s Chief Medical Correspondent Dr. Sanjay Gupta talks to Children’s Anne Stack, MD, about what precautions the hospital is taking to prepare for a potential influx of flu patients.
Ron Samuels, MD, MPH, associate medical director of the Children’s Hospital Primary Care Center, was interviewed last night on New England Cable News about how quickly and widely H1N1 can spread compared to the seasonal flu, the importance of mass vaccination and how Children’s is having a high volume of patients with flu-like illness in its emergency room.
Also in the United States, manufacturing difficulties are delaying the delivery of the H1N1 vaccine. The CDC said that only 16.1 million out of an expected 30 million doses had been shipped. While H1N1 vaccine shipment is delayed, increases in school closures, hospitalization rates, and 11 more pediatric influenza-related deaths point to an intensifying pandemic throughout the US.
If you’ve been reading up on vaccines lately (and it seems like everyone has), you’ve probably read that there’s a difference between the injectable and mist versions of vaccines. And if you’re like me, you might not know what that difference is. Well, here it is: the injectable version is made with “killed virus” and the mist version is made with “live virus.” If, like me, you’re still confused, here’s some help from Ken McIntosh, MD, an infectious disease and vaccine specialist at Children’s Hospital Boston.
The killed vaccine has been used for decades, and during that time has improved. The improvements are that it has become more potent and, most important, contains less of the possible non-influenza components that were in the earliest killed vaccines. These were (mostly) bits of egg protein coming from the embryonated eggs that were used to produce the vaccine. Those non-viral bits were responsible for most (although not all) the bad reactions (fever, headache, sore arms) that occurred in the old days. Now someone can expect a somewhat sore arm or nothing at all. Fevers and headaches are quite rare. Full story »
Do you have a Children's Hospital Boston story you'd like heard? By sharing your Children's story you can be a great source of inspiration and encouragement to families who are going through similar situations. And it’s a great way to find support by connecting with others. Share your story today »